Anaemia-related ribavirin dose reductions: contributing factors

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1021, 2004-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Virological Response in Patients with Hepatitis C Virus Genotype 1b and a High Viral Load: Impact of Peginterferon-α-2a plus Ribavirin Dose Reductions and Host-Related Factors

By Yamada Gotaro  

Clinical Drug Investigation, Vol. 28, Iss. 1, 2008-01 ,pp. : 9-16

Adis International

Access to resources Recommend Favorite

Ribavirin: Anaemia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1317, 2010-01 ,pp. : 38-39

Adis International

Access to resources Recommend Favorite

Ribavirin-Induced Anemia: Mechanisms, Risk Factors and Related Targets for Future Research

By  

Current Medicinal Chemistry, Vol. 13, Iss. 27, 2006-11 ,pp. : 3351-3357

Bentham Science Publishers

Access to resources Recommend Favorite

Peginterferon/ribavirin: Anaemia and neutropenia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1196, 2008-01 ,pp. : 32-32

Adis International

Access to resources Recommend Favorite

Dose Conversion and Cost Effectiveness of Erythropoietic Therapies in Chemotherapy-Related Anaemia: A Meta-Analysis

By James H. Rosberg  

Clinical Drug Investigation, Vol. 25, Iss. 1, 2005-01 ,pp. : 33-48

Adis International

Access to resources Recommend Favorite